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SHORT COMMUNICATION
Classical disseminated Kaposi's sarcoma in HIV-negative patients; an
unusually indolent subtype
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'Department ofOncology, Tel Aviv Sourasky Medical Center, Sackler School ofMedicine, Tel Aviv University, Tel Aviv;
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Summary Kaposi's sarcoma is a rare neoplasm of characteristic chronicity. The classical form which occurs
most often in elderly men of Eastern European origin, comprises both an indolent, cutaneous type marked by
spontaneous regression with prolonged survival, and a rarer, disseminated variant is more fulminant.
Seven elderly Jewish patients with classical, disseminated, visceral Kaposi's sarcoma were studied; they were
neither homosexual nor drug-abusers. All immunologic parameters were normal and serum tests for HIV
antibodies, CMV, and EBV were negative.
Five of these patients were treated and four responded well, including two complete remissions. The
prolonged survival of these patients (82% at 5 years) suggests the existence of an indolent subtype or forme
fruste of the usually aggressive form of classical Kaposi's sarcoma.
Kaposi's sarcoma (KS), a previously rare tumour, has
become more prevalent over the last decade. The epide-
miological data suggest that KS, a multifocal neoplasm of
endothelial origin (Friedman-Kien & Saltzman, 1990), occurs
in four clinical settings, two of which have known geo-
graphical associations.
The first of the major presentations is classical European
KS (CKS), an indolent cutaneous entity primarily involving
the lower extremities, and prevalent among elderly men of
Mediterranean origin or of Eastern European Jewish back-
ground (Friedman-Kien & Saltzman, 1990; DiGiovanna &
Safai, 1981). The disseminated subtype of CKS is, however,
more rapidly progressive than cutaneous CKS.
The second major presentation is the aggressive lympha-
denopathic/visceral form found among black Africans (HIV
status uncertain). This African KS tends to prevail in the
same regions where Burkitt's lymphoma (a lymphoprolifer-
ative disorder associated with Epstein-Barr virus) is endemic
(DiGiovanna & Safai, 1981). In the third, AIDS-related
form, the process is both visceral and cutaneous and often
aggressive, with a poor outlook (Ziegler et al., 1984). The
fourth KS group, is HIV-negative but exogenously immuno-
suppressed as in the cases of transplant patients.
The first group, classical KS, may include a previously
unrecognised indolent variety of its more aggressive, dis-
seminated subgroup. Previously, there have been sporadic
case reports of response to treatment (Templeton, 1976; Lor-
ing & Wolman, 1965; Halperin, 1988) usually without refer-
ence to HIV status. However, we are able to present a group
with 80% response who had biopsy-confirmed cases of vis-
cerally and cutaneously disseminated KS and who were HIV
negative, non-homosexual, non-drug users, and non-immuno-
suppressed. Our patients may constitute the first such series
with prolonged follow-up of their response to treatment.
Patients and methods
During the period 1980-1991, 103 diagnosed KS patients
were referred to the Tel Aviv and Northern Israel Oncology
Centers. Of this group, 100 (97%) had classical, indolent KS.
in keeping with the Taylor classification of the indolent
variety (Taylor et al., 1971). Of these, a small subset of seven
patients initially presented with non-specific signs and symp-
toms but were found, on tissue biopsy, to have stage IV -
disseminated - Kaposi's sarcoma according to accepted
criteria (Krigel et al., 1983; Mitsuyasu & Groopman, 1984).
The clinical and immunological/infectious features of the
seven were examined.
The clinical findings are summarised in Table I. There was
a male sex predominance (5:2), and six of the seven were
over 65 years of age (range 47-82). The most common
symptom was painless, cutaneous, darkened, nodularity, seen
in six of the seven patients. Although the mean duration of
the nodules at time of diagnosis had been 34 months, there
were two cases in which they had been noted for more than 5
years. The second most common type of complaint, found in
five of the seven patients, consisted of nonspecific indicators
of systemic disease, such as dysphagia, melena, and abdom-
inal pain. There was a complaint of right shoulder pain and
one finding of subclavicular mass. In the one patient who
had no skin lesions, widespread small intestinal tumour was
detected at laparotomy. In two patients, there had been no
complaints at all and only a slowly progressive red skin rash
had brought them to medical attention.
All patients denied intravenous drug use, homosexuality,
steroid or other immunosuppressant usage, and history of
blood transfusion. Routine laboratory tests were normal. All
were tested twice for HIV antibody and CMV antigen, using
ELISA, and found negative; in one patient with uncertain
progress, a Western blot test for the HIV antigen was addi-
tionally performed and proved to be negative. EBV antigen,
checked by immunofluorescence, was likewise negative in all.
Five patients (Nos. 1, 2, 4, 5, 7) underwent testing of serum
immunoglobulins, CD4 lymphocyte count, and helper/sup-
pressor ratio, with all results within normal limits.
In this group of seven patients, classical KS was the sole
oncological entity found. Because of the age of the group
(mean 71 years) and the sporadic recurrences of minimal
symptoms, the patients received individualised treatment.
Four (Nos. 3, 4, 5, 6) got combination chemotherapy follow-
ed by radiotherapy. One (No. 2) was treated only with
aggressive chemotherapy. The remaining two patients (Nos.
1, 7) were observed but not treated because of their clinically
very mild symptoms.
Results
Four of the five symptomatic patients (Nos. 3, 4, 5, 6)
became symptom free after treatment and two (Nos. 4, 5)
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Table I Clinical features at presentation of seven patients with disseminated KS
Survival (mths) Survival (mths)
since first since disseminated Latest
Patients Age/Sex Site involved at diagnosis Therapy clinical signs disease status
1 82/M Cutaneous; L.N.; None 15 15 AWD
small intestine
2 47/F Cutaneous; L.N.; VP-16 + VCR 87 6 DWD
(subcutaneous); Liver + DTIC
3 79/F Cutaneous; VP-16 + ActD 63 15 AWD
Larynx; + VCR
Hypopharynx xRT
4 79/M Cutaneous; Soft palate; ActD + VCR 101 87 NED
stomach xRT
5 69/M Cutaneous; VP-16 51 51 NED
Stomach; xRT
Small intestine
6 66/M Cutaneous; L.N.; VP-16 + ActD 28 13 AWD
Spleen + Dox
xRT
7 77/M Small intestine None 6 6 AWD
went on to complete remission. A fifth patient (No. 2) who
had had only aggressive chemotherapy died of progressive
disease 6 months after diagnosis and more than 7 years after
the first symptoms.
Of the seven disseminated KS patients followed-up for an
average of 27.5 months (range 6-87 months), there were two
complete remissions, one death, and four patients alive and
asymptomatic but with persisting evidence of disseminated
disease. The 5 year actuarial survival from time of diagnosis
is 82%.
Discussion
The four major varieties of KS- classical, African, immuno-
suppressive therapy-related, and AIDS-related, are uncom-
mon; only several hundred cases of classical KS have been
reported (Safai & Good, 1982). Yet classical KS itself mani-
fests at least three subtypes (Hood et al., 1982). The better-
known cutaneous variant runs a protracted course and those
affected usually die of unrelated causes (Reynolds et al.,
1962; Safai & Good, 1981) with an average survival of 8-13
years after diagnosis (Rothman, 1962). The nodular form of
the disease is characterised by locally aggressive lesions which
may appear as fungating, exophytic, ulcerating growths or as
a diffuse infiltrative process involving large areas of skin and
subcutaneous tissue, with bone involvement common. The
third and disseminated form of the disease, the least common
KS seen in Europeans, presents widespread cutaneous lesions
as well as lymph node and visceral involvement. There is a
typically rapid progression ending in death within three years
(Hood et al., 1982).
We report the cases of seven patients who presented with
classical KS of this third, disseminated subtype, yet who have
manifested extraordinary long term survival. The group was
typical in its age distribution (mean age 71), and in the 10:1
male:female ratio (Cox & Helwig, 1959). Other aspects of the
patients' histories were also consonant with those associated
with classical KS; they were Jewish, and lacked risk factors
for other non-classical types of KS (homosexuality, history of
viral or drug-induced immunosuppressive exposure, other
neoplasms). All had generalised cutaneous involvement of the
extremities, genitals, trunk, lymph nodes, and visceral organs
but with biopsy-established biological indolence (Taylor et
al., 1971). Yet, the disseminated nature of their disease met
the criteria of two staging systems (Krigel, 1983; Mitsuyasu,
1984). Negative results to multiple serological testing of HIV
antibodies, and normal immunological test results served to
exclude the diagnosis of a non-classical KS.
The five treated patients received radiotherapy and/or
chemotherapy with one early post-treatment death occurring
in a patient who had been symptomatic for 7 years. Two
patients were so mildly symptomatic that they were not
treated.
This group of patients with all the pathological and clinical
features of the more aggressive disseminated presentation of
classical KS has achieved an exceptional 82% survival at 5
post-diagnosis years; we propose that this may be a pre-
viously unrecognised further subtype or forme fruste of clas-
sical disseminated KS.
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